ES2128052T3 - Procedimiento para la preparacion de 4-amino-delta 4-3-cetoesteroides pasando por 4-nitro-delta 4-3-cetoesteroides. - Google Patents

Procedimiento para la preparacion de 4-amino-delta 4-3-cetoesteroides pasando por 4-nitro-delta 4-3-cetoesteroides.

Info

Publication number
ES2128052T3
ES2128052T3 ES95915628T ES95915628T ES2128052T3 ES 2128052 T3 ES2128052 T3 ES 2128052T3 ES 95915628 T ES95915628 T ES 95915628T ES 95915628 T ES95915628 T ES 95915628T ES 2128052 T3 ES2128052 T3 ES 2128052T3
Authority
ES
Spain
Prior art keywords
cetoesteroides
delta
nitro
going
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95915628T
Other languages
English (en)
Inventor
Philip M Weintraub
Cynthia A Gates
Michael R Angelastro
Timothy T Curran
Gary A Flynn
Chi-Hsin R King
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2128052T3 publication Critical patent/ES2128052T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011—Unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA 4-NITRO- DL 4 -3CETOESTEROIDES, SU UTILIZACION COMO LIASA DE ESTEROIDES C{SUB,1720} E INHIBIDORES DE LA 5{AL}-REDUCTASA, Y A UN NUEVO PROCESO PARA PREPARAR EL COMPUESTO DE FORMULA (I), QUE COMPRENDE SECUENCIALMENTE: A) HACER REACCIONAR UN COMPUESTO DE BASE DE FORMULA (II) CON UNA CANTIDAD EFECTIVA DE UNA BASE FUERTE A TEMPERATURA ELEVADA O APROPIADA, PARA CREAR EL CORRESPONDIENTE DIENOLATO TERMODINAMICO, SEGUIDO DE LA ADICION DE UN AGENTE NITRATANTE NEUTRAL, PARA PRODUCIR EL 4-NITRO-ESTEROIDE; Y A CONTINUACION, B) HACER REACCIONAR EL 4-NITROESTEROIDE CON UN AGENTE REDUCTOR APROPIADO.
ES95915628T 1994-05-02 1995-04-11 Procedimiento para la preparacion de 4-amino-delta 4-3-cetoesteroides pasando por 4-nitro-delta 4-3-cetoesteroides. Expired - Lifetime ES2128052T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23143394A 1994-05-02 1994-05-02

Publications (1)

Publication Number Publication Date
ES2128052T3 true ES2128052T3 (es) 1999-05-01

Family

ID=22869232

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95915628T Expired - Lifetime ES2128052T3 (es) 1994-05-02 1995-04-11 Procedimiento para la preparacion de 4-amino-delta 4-3-cetoesteroides pasando por 4-nitro-delta 4-3-cetoesteroides.

Country Status (18)

Country Link
US (4) US5750744A (es)
EP (1) EP0758340B1 (es)
JP (1) JPH09512547A (es)
CN (1) CN1042540C (es)
AT (1) ATE175419T1 (es)
AU (1) AU686793B2 (es)
CA (1) CA2188760A1 (es)
DE (1) DE69507139T2 (es)
DK (1) DK0758340T3 (es)
ES (1) ES2128052T3 (es)
FI (1) FI964410L (es)
GR (1) GR3029433T3 (es)
HU (1) HUT75523A (es)
IL (1) IL113532A (es)
NO (1) NO964627L (es)
NZ (1) NZ283974A (es)
WO (1) WO1995029932A1 (es)
ZA (1) ZA953357B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
US20060247216A1 (en) * 2002-10-25 2006-11-02 Haj-Yehia Abdullah I Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
PL3395372T3 (pl) 2009-02-20 2022-07-25 EnhanX Biopharm Inc. Układ do dostarczania leków na bazie glutationu
CN102458374A (zh) 2009-05-06 2012-05-16 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB892620A (en) * 1957-07-20 1962-03-28 Syntex Sa Cyclopentanophenanthrene derivatives
US3014632A (en) * 1961-03-06 1961-12-26 American Can Co Divider
US3159622A (en) * 1963-03-22 1964-12-01 Searle & Co 17 alpha-(2-carboxyethyl)-17 belta-hydroxy-6-nitroandrost-4-en-3-one gamma-lactones
GB8503940D0 (en) * 1985-02-15 1985-03-20 Erba Farmitalia 4-substituted androstendione derivatives
NZ239141A (en) * 1990-08-01 1994-04-27 Merrell Dow Pharma 4-amino-delta-4,6-steroids; preparatory processes and pharmaceutical compositions
US5120840A (en) * 1990-08-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. 4-amino-4-ene-steroids and their use as 5α-reductase inhibitors
US5143909A (en) * 1991-03-19 1992-09-01 Merrell Dow Pharmaceuticals Inc. Aminosteroids in a method for inhibiting c17-20 lyase
US5218110A (en) * 1990-08-01 1993-06-08 Merrell Dow Pharmaceuticals 4-amino-Δ4 -steroids and their use as 5α-reductase inhibitors

Also Published As

Publication number Publication date
WO1995029932A1 (en) 1995-11-09
US5990328A (en) 1999-11-23
US5869475A (en) 1999-02-09
US5750744A (en) 1998-05-12
DK0758340T3 (da) 1999-08-30
NO964627L (no) 1997-01-02
ZA953357B (en) 1996-01-17
EP0758340A1 (en) 1997-02-19
FI964410A0 (fi) 1996-11-01
DE69507139T2 (de) 1999-09-30
AU2244995A (en) 1995-11-29
FI964410A7 (fi) 1996-11-01
IL113532A0 (en) 1995-07-31
NZ283974A (en) 1998-02-26
HUT75523A (en) 1997-05-28
CN1147258A (zh) 1997-04-09
IL113532A (en) 2000-02-17
AU686793B2 (en) 1998-02-12
JPH09512547A (ja) 1997-12-16
NO964627D0 (no) 1996-11-01
EP0758340B1 (en) 1999-01-07
ATE175419T1 (de) 1999-01-15
HU9603035D0 (en) 1997-01-28
CN1042540C (zh) 1999-03-17
CA2188760A1 (en) 1995-11-09
FI964410L (fi) 1996-11-01
US5965550A (en) 1999-10-12
GR3029433T3 (en) 1999-05-28
DE69507139D1 (de) 1999-02-18

Similar Documents

Publication Publication Date Title
BR9709427A (pt) Oxa ácidos e compostos relacionados para tratamento de condições da pele
MX9301536A (es) Agente para regular la condicion grasosa de la piel.
ES2168737T3 (es) Inhibidores de la oxido nitrico sintasa.
BR0109188A (pt) Diarilaminas 5-amida substituìdas como inibidores de mex
SE8604583L (sv) Uppfinningen henfor till ett foraktiverat organofilt lergelningsmedel for smorjfetter som er fortjockade med anvendning av gelningsmedlet
BR0209127A (pt) compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
CO4750758A1 (es) Compuestos de 5-amino-4-etilsulfinil-1-arilpirazol, composiciones que los contienen y procedimiento para su preparacion
PT98905A (pt) Processo para a preparacao de mono-hidrato de furoato de mometasona,e de composicoes farmaceuticas que o contem
ES2189768T3 (es) Sintesis regioselectiva de derivados de rapamicina.
BRPI0601896A (pt) composições que contêm microgéis e agentes espessantes
BR0005488A (pt) Processo para a preparação de carbonato de vinileno, e o uso do mesmo
ES2159919T3 (es) Procedimiento para la preparacion de compuestos de tipo ceramidas.
ES2152367T3 (es) Composiciones fertilizantes en emulsion agua en aceite.
BR0115952A (pt) Composição de emulsão para administração terapêutica, método de administração, processo para o preparo de uma formulação contendo derivados de fosfato de agentes de transferência de elétrons
BR0204678A (pt) Inibidor de nf-kb contendo derivado de ácido benzóico substituìdo como ingrediente ativo
ES2032955T3 (es) Sal sodica anhidra cristalina de 5-cloro-3-(2-tenoil)-2-oxindol-1-carboxamida.
ES2130312T3 (es) Nuevos derivados de tetrazina con actividad acaricida.
ES2128052T3 (es) Procedimiento para la preparacion de 4-amino-delta 4-3-cetoesteroides pasando por 4-nitro-delta 4-3-cetoesteroides.
ES2194535T3 (es) 4-trifluorometil-3-oxazolilpiridinas, procedimiento para su preparacion, agentes que las contien y su uso como agente parala lucha contra organismos dañinos.
ES2096973T3 (es) Fosfazenos que contienen radicales organicos de silicio, proceso para su preparacion, y su empleo.
ES2151980T3 (es) Procedimiento para eliminar mercurio del suelo.
ES2171943T3 (es) Nuevo procedimiento de isomerizacion del radical metilo en posicion 10 de derivados de eritromicina.
ES2187184T3 (es) Fosfoepoxidos, procedimiento de fabricacion y aplicaciones.
BRPI0413157A (pt) agente, kit, e, uso de um álcool alcoxilado
BR0308601A (pt) inibidores de carboxipeptidase b de plasma

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 758340

Country of ref document: ES